Source: National Library of Medicine
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of peptide-based medications used primarily to treat type 2 diabetes and obesity. They work by enhancing insulin secretion, lowering blood glucose, delaying gastric emptying, and promoting satiety. These agents also have beneficial effects on cardiovascular outcomes and are widely studied in metabolic disease management.